Celcuity Inc logo

CELC - Celcuity Inc Share Price

$5.32 0.0  0.0%

Last Trade - 21/10/20

Sector
Healthcare
Size
Micro Cap
Market Cap £42.3m
Enterprise Value £30.4m
Revenue £n/a
Position in Universe 4768th / 6436
Bullish
Bearish
Unlock CELC Revenue
Momentum
Relative Strength (%)
1m -11.7%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -67.1%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
0.000 0.000 0.000 0.000 0.000 0.000
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 30 June 2020, Celcuity Inc revenues was not reported. Net loss increased 25% to $4.4M. Higher net loss reflects Stock-Based Compensation increase from $202K to $559K (expense), Research & Development - Balancing value increase of 7% to $3.1M (expense), Interest Income decrease of 70% to $76K (income). Basic Earnings per Share excluding Extraordinary Items decreased from -$0.35 to -$0.43.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

CELC Revenue Unlock CELC Revenue

Net Income

CELC Net Income Unlock CELC Revenue

Normalised EPS

CELC Normalised EPS Unlock CELC Revenue

PE Ratio Range

CELC PE Ratio Range Unlock CELC Revenue

Dividend Yield Range

CELC Dividend Yield Range Unlock CELC Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
CELC EPS Forecasts Unlock CELC Revenue
Profile Summary

Celcuity, Inc. is a cellular analysis company. The Company is focused on discovering new cancer sub-types and commercializing diagnostic tests designed to significantly improve the clinical outcomes of cancer patients treated with targeted therapies. The Company’s proprietary CELx diagnostic platform uses a patient’s living tumor cells to identify the specific abnormal cellular process driving a patient’s cancer and the targeted therapy that best treats it. CELx platform provides traditional molecular diagnostics, which provides a snapshot of the genetic mutations present in a patient’s tumor because they analyze dead cells. Using dead cells prevents molecular diagnostics from analyzing in real-time the dynamic cellular activities, known as cell signaling, that regulate cell proliferation or survival.

Directors
Last Annual December 31st, 2019
Last Interim June 30th, 2020
Incorporated September 15, 2017
Public Since September 20, 2017
No. of Shareholders: 44
No. of Employees: 27
Sector Healthcare
Industry Biotechnology & Medical Research
Index Nasdaq Composite ,
Exchange NASDAQ Capital Market
Shares in Issue 10,289,253
Free Float (0.0%)
Eligible for
ISAs
SIPPs
CELC Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for CELC
Upcoming Events for CELC
Thursday 5th November, 2020 Estimate
Q3 2020 Celcuity Inc Earnings Release
Wednesday 10th March, 2021 Estimate
Q4 2020 Celcuity Inc Earnings Release
Frequently Asked Questions for Celcuity Inc
What is the Celcuity Inc share price?

As of 21/10/20, shares in Celcuity Inc are trading at $5.32, giving the company a market capitalisation of £42.3m. This share price information is delayed by 15 minutes.

How has the Celcuity Inc share price performed this year?

Shares in Celcuity Inc are currently trading at $5.32 and the price has moved by -67.66% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Celcuity Inc price has moved by -71.73% over the past year.

What are the analyst and broker recommendations for Celcuity Inc?

Of the analysts with advisory recommendations for Celcuity Inc, there are there are currently 0 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Celcuity Inc is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Celcuity Inc next release its financial results?

Celcuity Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-06-30
What is the Celcuity Inc dividend yield?

Celcuity Inc does not currently pay a dividend.

Does Celcuity Inc pay a dividend?

Celcuity Inc does not currently pay a dividend.

When does Celcuity Inc next pay dividends?

Celcuity Inc does not currently pay a dividend.

How do I buy Celcuity Inc shares?

To buy shares in Celcuity Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Celcuity Inc?

Shares in Celcuity Inc are currently trading at $5.32, giving the company a market capitalisation of £42.3m.

Where are Celcuity Inc shares listed? Where are Celcuity Inc shares listed?

Here are the trading details for Celcuity Inc:

Country of listing: United States
Exchange: NAQ
Ticker Symbol: CELC
What kind of share is Celcuity Inc?

Based on an overall assessment of its quality, value and momentum, Celcuity Inc is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Celcuity Inc share price forecast 2020?

Shares in Celcuity Inc are currently priced at $5.32. At that level they are trading at 0.154% discount to the analyst consensus target price of 0.00.

Analysts covering Celcuity Inc currently have a consensus Earnings Per Share (EPS) forecast of -0.82 for the next financial year.

How can I tell whether the Celcuity Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Celcuity Inc. Over the past six months, the relative strength of its shares against the market has been -15.96%. At the current price of $5.32, shares in Celcuity Inc are trading at -26.01% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Celcuity Inc PE Ratio?

We were not able to find PE ratio data for Celcuity Inc.

Who are the key directors of Celcuity Inc?

We were unable to find the directors for Celcuity Inc.

Who are the major shareholders of Celcuity Inc?

Here are the top five shareholders of Celcuity Inc based on the size of their shareholding:

Sullivan (Brian F) Individual Investor
Percentage owned: 27.16% (2.80m shares)
Laing (Lance G Ph.D.) Individual Investor
Percentage owned: 12.35% (1.27m shares)
Frontier Wealth Management LLC Investment Advisor
Percentage owned: 7.19% (740k shares)
Globe Resources Group, L.L.C. Corporation
Percentage owned: 6.61% (681k shares)
Gagnon Securities LLC Investment Advisor/Hedge Fund
Percentage owned: 3.54% (364k shares)
Similar to CELC
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.